Recurrent Mycosis Fungoides Recruiting Phase 1 Trials for Obinutuzumab (DB08935)

Also known as: Mycosis fungoides recurrent

IndicationStatusPhase
DBCOND0080283 (Recurrent Mycosis Fungoides)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs